Johnson & Johnson MedTech (NYSE: JNJ) shared extended clinical findings from its Shockwave intravascular lithotripsy system, from a study aimed at clearing calcified vessel blockages below the knee in patients with peripheral artery disease. In late-breaking data presented at the Vascular InterVentional Advances 2026 conference in Las Vegas, … [Read more...] about J&J delivers Shockwave data sustaining below-the-knee gains for two years
peripheral artery disease
Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
Medtronic (NYSE:MDT) has secured a breakthrough designation from the FDA for a version of its drug-coated balloon aimed at unblocking arteries below the knee, following years of development. The In.Pact BTK catheter is slated for an international, randomized pivotal trial that plans to enroll about 400 participants with peripheral artery disease … [Read more...] about Medtronic snags breakthrough designation for below-the-knee drug-coated balloon
Boston Scientific’s Dr. Michael Jaff on the future of peripheral intervention
Advanced technologies have the potential to take peripheral therapy "to a different stratosphere," says Dr. Michael Jaff, the chief medical officer and VP of the Boston Scientific Peripheral Interventions business. He characterized them as similar to the ability to combine devices with drugs, which he called the biggest transformational change … [Read more...] about Boston Scientific’s Dr. Michael Jaff on the future of peripheral intervention



